These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38503729)

  • 81. Development and mechanism investigation of a new piperlongumine derivative as a potent anti-inflammatory agent.
    Sun LD; Wang F; Dai F; Wang YH; Lin D; Zhou B
    Biochem Pharmacol; 2015 Jun; 95(3):156-69. PubMed ID: 25850000
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
    Hassan HT; Zander A
    Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Piperlongumine induces gastric cancer cell apoptosis and G2/M cell cycle arrest both in vitro and in vivo.
    Duan C; Zhang B; Deng C; Cao Y; Zhou F; Wu L; Chen M; Shen S; Xu G; Zhang S; Duan G; Yan H; Zou X
    Tumour Biol; 2016 Aug; 37(8):10793-804. PubMed ID: 26874726
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Piperlongumine induces cell death through ROS-mediated CHOP activation and potentiates TRAIL-induced cell death in breast cancer cells.
    Jin HO; Lee YH; Park JA; Lee HN; Kim JH; Kim JY; Kim B; Hong SE; Kim HA; Kim EK; Noh WC; Kim JI; Chang YH; Hong SI; Hong YJ; Park IC; Lee JK
    J Cancer Res Clin Oncol; 2014 Dec; 140(12):2039-46. PubMed ID: 25023940
    [TBL] [Abstract][Full Text] [Related]  

  • 85. TLR4/NF-κB axis induces fludarabine resistance by suppressing TXNIP expression in acute myeloid leukemia cells.
    Huy H; Kim TD; Kim WS; Kim DO; Byun JE; Kim MJ; Park YJ; Yoon SR; Noh JY; Lee J; Lee KH; Choi I; Jung H
    Biochem Biophys Res Commun; 2018 Nov; 506(1):33-40. PubMed ID: 30336978
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells.
    Cho H; Jang JE; Eom JI; Jeung HK; Chung H; Kim JS; Cheong JW; Min YH
    Exp Hematol Oncol; 2021 Apr; 10(1):28. PubMed ID: 33858507
    [TBL] [Abstract][Full Text] [Related]  

  • 87. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.
    Al-Mawali A; Pinto AD; Al-Zadjali S
    Acta Haematol; 2017; 138(3):175-181. PubMed ID: 29065396
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Ethyl acetate extract of Caesalpinia sappan L. inhibited acute myeloid leukemia via ROS-mediated apoptosis and differentiation.
    Ma HY; Wang CQ; He H; Yu ZY; Tong Y; Liu G; Yang YQ; Li L; Pang L; Qi HY
    Phytomedicine; 2020 Mar; 68():153142. PubMed ID: 32045840
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
    Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
    Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Piperlongumine inhibits migration of glioblastoma cells via activation of ROS-dependent p38 and JNK signaling pathways.
    Liu QR; Liu JM; Chen Y; Xie XQ; Xiong XX; Qiu XY; Pan F; Liu D; Yu SB; Chen XQ
    Oxid Med Cell Longev; 2014; 2014():653732. PubMed ID: 24967005
    [TBL] [Abstract][Full Text] [Related]  

  • 91. PIM and AKT kinase inhibitors show synergistic cytotoxicity in acute myeloid leukaemia that is associated with convergence on mTOR and MCL1 pathways.
    Meja K; Stengel C; Sellar R; Huszar D; Davies BR; Gale RE; Linch DC; Khwaja A
    Br J Haematol; 2014 Oct; 167(1):69-79. PubMed ID: 24975213
    [TBL] [Abstract][Full Text] [Related]  

  • 92. EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax.
    Fooks K; Galicia-Vazquez G; Gife V; Schcolnik-Cabrera A; Nouhi Z; Poon WWL; Luo V; Rys RN; Aloyz R; Orthwein A; Johnson NA; Hulea L; Mercier FE
    J Exp Clin Cancer Res; 2022 Dec; 41(1):340. PubMed ID: 36482393
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors.
    Larocca LM; Teofili L; Leone G; Sica S; Pierelli L; Menichella G; Scambia G; Benedetti Panici P; Ricci R; Piantelli M
    Br J Haematol; 1991 Dec; 79(4):562-6. PubMed ID: 1772777
    [TBL] [Abstract][Full Text] [Related]  

  • 94. ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia.
    Mohd Amin A; Panneerselvan N; Md Noor S; Mohtaruddin N; Sathar J; Norbaya WS; Osman R; Kee LH; Mohd Yaakub WH; Cheong SK; Abdullah M
    Malays J Pathol; 2023 Apr; 45(1):65-76. PubMed ID: 37119247
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway.
    Thongsom S; Suginta W; Lee KJ; Choe H; Talabnin C
    Apoptosis; 2017 Nov; 22(11):1473-1484. PubMed ID: 28913568
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A novel approach for relapsed/refractory FLT3
    Li KX; Wu HY; Pan WY; Guo MQ; Qiu DZ; He YJ; Li YH; Yang DH; Huang YX
    Mol Cancer; 2022 Mar; 21(1):66. PubMed ID: 35246156
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells.
    Estrov Z; Shishodia S; Faderl S; Harris D; Van Q; Kantarjian HM; Talpaz M; Aggarwal BB
    Blood; 2003 Aug; 102(3):987-95. PubMed ID: 12689943
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Role of NF-κB inhibitor in Acute Myeloid Leukemia].
    Wang WL; Xu QZ; Mu XH; Wang L; Zhang LY; Xu J; Gao YD; Cheng T; Yuan WP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1622-1626. PubMed ID: 28024466
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Blockade of JAK2/STAT3 intensifies the anti-tumor activity of arsenic trioxide in acute myeloid leukemia cells: Novel synergistic mechanism via the mediation of reactive oxygen species.
    Mesbahi Y; Zekri A; Ghaffari SH; Tabatabaie PS; Ahmadian S; Ghavamzadeh A
    Eur J Pharmacol; 2018 Sep; 834():65-76. PubMed ID: 30012499
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Reactive oxygen species activate differentiation gene transcription of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway.
    Lam CF; Yeung HT; Lam YM; Ng RK
    Leuk Res; 2018 May; 68():112-119. PubMed ID: 29609096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.